Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8988
Corporate User License Price USD 375
Corporate User License Price INR 26963
Site License Price USD 250
Site License Price INR 17975
Request a Quote

Report Title

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review



Executive Summary

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlaxoSmithKline Pharmaceuticals Ltd (GSK India), a subsidiary of GlaxoSmithKline Plc manufactures and markets prescription medicines and vaccines. The prescription medicines includes therapeutic areas such as, analgesic, anti-infective, anti-inflammatory, anti-parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, central nervous system (CNS) and oncology. The company offers a range of vaccines for the prevention of hepatitis A, hepatitis B, influenzae, diphtheria, tetanus, pertussis, rotavirus, tetanus toxoid, reduced diphtheria toxoid, human papillomavirus vaccine and others. GSK India is headquartered in Mumbai, Maharashtra, India.

GlaxoSmithKline Pharmaceuticals Ltd Key Recent Developments

May 24,2018: GlaxoSmithKline Pharmaceuticals delivers strong Q4 performance with Revenue of 749 Cr and PBT before exceptionals growing 14%

Mar 16,2018: GlaxoSmithKline Pharmaceuticals: Change in Directorate

Feb 26,2018: Champion Baseball Pitcher Justin Verlander Teams Up with FLONASE Allergy Relief for a Homerun Allergy Season

Feb 07,2018: GlaxoSmithKline: Full year and fourth quarter 2017

Feb 02,2018: GlaxoSmithKline Pharmaceuticals delivers strong Q3 performance with Revenue of 704 Cr.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

GlaxoSmithKline Pharmaceuticals Ltd-Key Facts 6

GlaxoSmithKline Pharmaceuticals Ltd-Key Employees 7

GlaxoSmithKline Pharmaceuticals Ltd-Key Employee Biographies 8

GlaxoSmithKline Pharmaceuticals Ltd-Key Operational Employees 9

GlaxoSmithKline Pharmaceuticals Ltd-Major Products and Services 10

GlaxoSmithKline Pharmaceuticals Ltd-History 16

GlaxoSmithKline Pharmaceuticals Ltd-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Joint Venture 18

Section 2-Company Analysis 19

Company Overview 19

GlaxoSmithKline Pharmaceuticals Ltd-Business Description 20

GlaxoSmithKline Pharmaceuticals Ltd-Corporate Strategy 21

GlaxoSmithKline Pharmaceuticals Ltd-SWOT Analysis 22

SWOT Analysis-Overview 22

GlaxoSmithKline Pharmaceuticals Ltd-Strengths 22

GlaxoSmithKline Pharmaceuticals Ltd-Weaknesses 23

GlaxoSmithKline Pharmaceuticals Ltd-Opportunities 24

GlaxoSmithKline Pharmaceuticals Ltd-Threats 25

GlaxoSmithKline Pharmaceuticals Ltd-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 31

Financial Performance 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

GlaxoSmithKline Pharmaceuticals Ltd, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

May 24, 2018: GlaxoSmithKline Pharmaceuticals delivers strong Q4 performance with Revenue of 749 Cr and PBT before exceptionals growing 14% 36

Mar 16, 2018: GlaxoSmithKline Pharmaceuticals: Change in Directorate 37

Feb 07, 2018: GlaxoSmithKline: Full year and fourth quarter 2017 38

Feb 02, 2018: GlaxoSmithKline Pharmaceuticals delivers strong Q3 performance with Revenue of 704 Cr. 64

Oct 25, 2017: GlaxoSmithKline Pharmaceuticals India records a Revenue increase of 5% 65

Oct 25, 2017: GlaxoSmithKline Pharmaceuticals Appointment of Ms. Puja Thakur as Whole-time Director and Chief Financial officer 66

Jul 25, 2017: GlaxoSmithKline Pharmaceuticals QI performance temporarily impacted by GST trade channel destocking whilst fundamentals remain intact 67

May 19, 2017: GlaxoSmithKline Pharmaceuticals records 11% Sales growth for Q4, FY 2016-17 68

Feb 11, 2017: GlaxoSmithKline Pharmaceuticals announces executive director change 69

Section 6-Appendix 70

Methodology 70

Ratio Definitions 70

About GlobalData 74

Contact Us 74

Disclaimer 74

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

GlaxoSmithKline Pharmaceuticals Ltd, Performance Chart (2015-2018) 31

GlaxoSmithKline Pharmaceuticals Ltd, Ratio Charts 32

GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 34

List of Tables

GlaxoSmithKline Pharmaceuticals Ltd, Key Facts 6

GlaxoSmithKline Pharmaceuticals Ltd, Key Employees 7

GlaxoSmithKline Pharmaceuticals Ltd, Key Employee Biographies 8

GlaxoSmithKline Pharmaceuticals Ltd, Key Operational Employees 9

GlaxoSmithKline Pharmaceuticals Ltd, Major Products and Services 10

GlaxoSmithKline Pharmaceuticals Ltd, History 16

GlaxoSmithKline Pharmaceuticals Ltd, Joint Venture 18

GlaxoSmithKline Pharmaceuticals Ltd, Key Competitors 26

GlaxoSmithKline Pharmaceuticals Ltd, Ratios based on current share price 27

GlaxoSmithKline Pharmaceuticals Ltd, Annual Ratios 28

GlaxoSmithKline Pharmaceuticals Ltd, Annual Ratios (Cont...1) 29

GlaxoSmithKline Pharmaceuticals Ltd, Annual Ratios (Cont...2) 30

GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33

GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34

GlaxoSmithKline Pharmaceuticals Ltd, Recent Deals Summary 35

Currency Codes 70

Capital Market Ratios 70

Equity Ratios 71

Profitability Ratios 71

Cost Ratios 72

Liquidity Ratios 72

Leverage Ratios 73

Efficiency Ratios 73

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Sunzen Biotech Berhad

Morepen Laboratories Ltd

Dr. Reddy's Laboratories Ltd

Bliss GVS Pharma Ltd

Aurobindo Pharma Ltd

Ambalal Sarabhai Enterprises Ltd

Aarti Drugs Ltd

GlaxoSmithKline Pharmaceuticals Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand